[TANJONG] QoQ Quarter Result on 31-Jan-2009 [#4]

Stock
[TANJONG] TANJONG PUBLIC LIMITED COMPANY
Announcement Date
31-Mar-2009
Admission Sponsor
-
Sponsor
-
Financial Year
31-Jan-2009
Quarter
31-Jan-2009 [#4]
Profit Trend
QoQ- -70.16%
YoY- -80.4%
Quarter Report
Latest QR
Upcoming QR
TANJONG's Result
TANJONG's Financial Summary
View:
Show?
Quarter Result
31/10/09 31/07/09 30/04/09 31/01/09 31/10/08 31/07/08 30/04/08 CAGR
Revenue 985,175 997,550 978,819 1,057,541 986,513 840,286 809,515 13.94%
PBT 252,581 262,609 269,364 148,221 139,128 190,337 271,150 -4.60%
Tax -54,104 -56,769 -53,048 -105,584 -25,945 -28,265 -40,466 21.30%
NP 198,477 205,840 216,316 42,637 113,183 162,072 230,684 -9.51%
-
NP to SH 177,763 181,529 191,413 28,987 97,127 136,687 200,967 -7.83%
-
Tax Rate 21.42% 21.62% 19.69% 71.23% 18.65% 14.85% 14.92% -
Total Cost 786,698 791,710 762,503 1,014,904 873,330 678,214 578,831 22.62%
-
Net Worth 4,153,717 4,202,471 3,975,841 3,705,014 4,136,666 3,987,712 3,754,018 6.95%
Dividend
31/10/09 31/07/09 30/04/09 31/01/09 31/10/08 31/07/08 30/04/08 CAGR
Div 70,572 70,578 70,565 151,183 70,557 70,561 70,564 0.00%
Div Payout % 39.70% 38.88% 36.87% 521.56% 72.64% 51.62% 35.11% -
Equity
31/10/09 31/07/09 30/04/09 31/01/09 31/10/08 31/07/08 30/04/08 CAGR
Net Worth 4,153,717 4,202,471 3,975,841 3,705,014 4,136,666 3,987,712 3,754,018 6.95%
NOSH 403,273 403,308 403,229 403,157 403,183 403,206 403,224 0.00%
Ratio Analysis
31/10/09 31/07/09 30/04/09 31/01/09 31/10/08 31/07/08 30/04/08 CAGR
NP Margin 20.15% 20.63% 22.10% 4.03% 11.47% 19.29% 28.50% -
ROE 4.28% 4.32% 4.81% 0.78% 2.35% 3.43% 5.35% -
Per Share
31/10/09 31/07/09 30/04/09 31/01/09 31/10/08 31/07/08 30/04/08 CAGR
RPS 244.29 247.34 242.74 262.31 244.68 208.40 200.76 13.93%
EPS 44.08 45.01 47.47 7.19 24.09 33.90 49.84 -7.84%
DPS 17.50 17.50 17.50 37.50 17.50 17.50 17.50 0.00%
NAPS 10.30 10.42 9.86 9.19 10.26 9.89 9.31 6.94%
Adjusted Per Share Value based on latest NOSH - 403,157
31/10/09 31/07/09 30/04/09 31/01/09 31/10/08 31/07/08 30/04/08 CAGR
RPS 244.30 247.36 242.72 262.24 244.63 208.37 200.74 13.94%
EPS 44.08 45.01 47.46 7.19 24.08 33.89 49.83 -7.82%
DPS 17.50 17.50 17.50 37.49 17.50 17.50 17.50 0.00%
NAPS 10.30 10.4209 9.859 9.1874 10.2578 9.8884 9.3089 6.95%
Price Multiplier on Financial Quarter End Date
31/10/09 31/07/09 30/04/09 31/01/09 31/10/08 31/07/08 30/04/08 CAGR
Date 30/10/09 31/07/09 30/04/09 30/01/09 31/10/08 31/07/08 30/04/08 -
Price 15.16 15.20 14.10 13.50 11.80 13.10 16.10 -
P/RPS 6.21 6.15 5.81 5.15 4.82 6.29 8.02 -15.63%
P/EPS 34.39 33.77 29.70 187.76 48.98 38.64 32.30 4.25%
EY 2.91 2.96 3.37 0.53 2.04 2.59 3.10 -4.11%
DY 1.15 1.15 1.24 2.78 1.48 1.34 1.09 3.62%
P/NAPS 1.47 1.46 1.43 1.47 1.15 1.32 1.73 -10.26%
Price Multiplier on Announcement Date
31/10/09 31/07/09 30/04/09 31/01/09 31/10/08 31/07/08 30/04/08 CAGR
Date 11/12/09 30/09/09 29/06/09 31/03/09 11/12/08 25/09/08 20/06/08 -
Price 16.44 15.00 13.70 13.80 13.20 12.90 14.20 -
P/RPS 6.73 6.06 5.64 5.26 5.39 6.19 7.07 -3.22%
P/EPS 37.30 33.33 28.86 191.93 54.79 38.05 28.49 19.61%
EY 2.68 3.00 3.46 0.52 1.82 2.63 3.51 -16.42%
DY 1.06 1.17 1.28 2.72 1.33 1.36 1.23 -9.41%
P/NAPS 1.60 1.44 1.39 1.50 1.29 1.30 1.53 3.01%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment